<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00889876</url>
  </required_header>
  <id_info>
    <org_study_id>2008-000461-28</org_study_id>
    <nct_id>NCT00889876</nct_id>
  </id_info>
  <brief_title>Effect of Exercise or Metformin on Nocturnal Blood Pressure and Other Risk Factors for CVD Among Obese Adolescents</brief_title>
  <official_title>Effect of Exercise or Metformin on Nocturnal Blood Pressure and Other Risk Factors for Cardiovascular Disease (CVD) Among Obese Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to, among obese adolescents, study impact of regular physical activity or
      metformin therapy on nocturnal blood pressure and related cardiovascular disease risk
      factors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Forty subjects will be assigned to the exercise intervention group, thirty to the metformin
      therapy group and thirty to the control group. Group I will be treated daily with metformin.
      Group II will perform exercise (endurance) three times/week with a personal coach and group
      III will serve as control. All participants will be examined at baseline, after 3 months of
      intervention, after 6 months of intervention and after one year of intervention. Examination
      includes anthropometric measures, measures of ambulatory 24-h blood pressure and insulin
      sensitivity, measures for function and structure of the heart and vessels, analysis of
      atherogenic factors in the blood, aerobic fitness testing and measurement of daily physical
      activity.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2009</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Normalization of nocturnal blood pressure dipping</measure>
    <time_frame>Before and 3, 6 and 12 months of intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Normalization of insulin metabolism and cardiovascular structure and function</measure>
    <time_frame>Before and 3, 6 and 12 months of intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Metformin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin group</intervention_name>
    <description>2000 mg/day for one year</description>
    <arm_group_label>Metformin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>3 times/week with a personal coach for one year. Endurance training.</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 13-19 years old at inclusion date

          -  Obesity according to gender and age specific BMI (Cole 2000)

          -  Reduced nocturnal systolic blood pressure fall (&lt; 10%)

          -  Signed informed consent by patient and parents

        Exclusion Criteria:

          -  Cardiovascular disease

          -  Insulin dependent diabetes mellitus

          -  Patient on medications that are contraindicated during Metformin treatment

          -  Pregnancy

          -  Mental or physical conditions limiting the ability to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claude Marcus, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claude Marcus, Professor</last_name>
    <phone>+468 585 814 19</phone>
    <email>claude.marcus@ki.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Westerstahl, PhD</last_name>
    <phone>+468 585 873 96</phone>
    <email>maria.westerstahl@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Karolinska Institutet, Karolinska University Hospital Huddinge</name>
      <address>
        <city>Stockholm</city>
        <zip>141 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Westerst√•hl, PhD</last_name>
      <phone>+468 585 873 96</phone>
      <email>maria.westerstahl@ki.se</email>
    </contact>
    <contact_backup>
      <last_name>Pernilla Hedvall, PhDstudent</last_name>
      <phone>+468 585 873 96</phone>
      <email>pernilla.hedvall@ki.se</email>
    </contact_backup>
    <investigator>
      <last_name>Claude Marcus, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2009</study_first_submitted>
  <study_first_submitted_qc>April 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2009</study_first_posted>
  <last_update_submitted>February 3, 2011</last_update_submitted>
  <last_update_submitted_qc>February 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2011</last_update_posted>
  <responsible_party>
    <name_title>Professor Claude Marcus, Karolinska Institutet</name_title>
    <organization>Karolinska Institutet</organization>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Adolescents</keyword>
  <keyword>Nocturnal blood pressure reduction</keyword>
  <keyword>Insulin metabolism</keyword>
  <keyword>Cardiovascular structure and function</keyword>
  <keyword>Treatment</keyword>
  <keyword>Exercise</keyword>
  <keyword>Metformin</keyword>
  <keyword>Insulin</keyword>
  <keyword>Blood glucose</keyword>
  <keyword>Impaired nocturnal blood pressure reduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

